CN104630248A - Aryl sulfatase gene, protein encoded by aryl sulfatase gene as well as immobilization method and application of protein - Google Patents
Aryl sulfatase gene, protein encoded by aryl sulfatase gene as well as immobilization method and application of protein Download PDFInfo
- Publication number
- CN104630248A CN104630248A CN201510084197.6A CN201510084197A CN104630248A CN 104630248 A CN104630248 A CN 104630248A CN 201510084197 A CN201510084197 A CN 201510084197A CN 104630248 A CN104630248 A CN 104630248A
- Authority
- CN
- China
- Prior art keywords
- arylsulfatase
- aryl sulfatase
- gene
- restructuring
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108060007951 sulfatase Proteins 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 title abstract description 7
- 102000004169 proteins and genes Human genes 0.000 title abstract description 6
- 102000009133 Arylsulfatases Human genes 0.000 claims abstract description 56
- 229920001817 Agar Polymers 0.000 claims abstract description 31
- 239000008272 agar Substances 0.000 claims abstract description 30
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 241000588724 Escherichia coli Species 0.000 claims abstract description 9
- 239000002122 magnetic nanoparticle Substances 0.000 claims abstract description 9
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 8
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 claims description 8
- 229920000936 Agarose Polymers 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000519590 Pseudoalteromonas Species 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000011553 magnetic fluid Substances 0.000 claims description 5
- 239000002539 nanocarrier Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005642 Oleic acid Substances 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 238000000975 co-precipitation Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 241000212297 Pelvetia Species 0.000 claims 2
- 238000005336 cracking Methods 0.000 claims 2
- 238000013016 damping Methods 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 239000011534 wash buffer Substances 0.000 claims 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 102000057593 human F8 Human genes 0.000 claims 1
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000010355 oscillation Effects 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 229940047431 recombinate Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 abstract description 16
- 102000004190 Enzymes Human genes 0.000 abstract description 12
- 108090000790 Enzymes Proteins 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 230000003100 immobilizing effect Effects 0.000 abstract description 4
- 241000590033 Pseudoalteromonas carrageenovora Species 0.000 abstract description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000000746 purification Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000007885 magnetic separation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 101100110035 Escherichia coli (strain K12) aslA gene Proteins 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 101150043038 atsA gene Proteins 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- OQWQTGBOFPJOIF-DLOVCJGASA-N Ala-Lys-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N OQWQTGBOFPJOIF-DLOVCJGASA-N 0.000 description 1
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- CYBJZLQSUJEMAS-LFSVMHDDSA-N Ala-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)N)O CYBJZLQSUJEMAS-LFSVMHDDSA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 1
- ZUVMUOOHJYNJPP-XIRDDKMYSA-N Arg-Trp-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZUVMUOOHJYNJPP-XIRDDKMYSA-N 0.000 description 1
- ORXCYAFUCSTQGY-FXQIFTODSA-N Asn-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N ORXCYAFUCSTQGY-FXQIFTODSA-N 0.000 description 1
- JREOBWLIZLXRIS-GUBZILKMSA-N Asn-Glu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JREOBWLIZLXRIS-GUBZILKMSA-N 0.000 description 1
- GYOHQKJEQQJBOY-QEJZJMRPSA-N Asn-Glu-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N GYOHQKJEQQJBOY-QEJZJMRPSA-N 0.000 description 1
- RKNIUWSZIAUEPK-PBCZWWQYSA-N Asp-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N)O RKNIUWSZIAUEPK-PBCZWWQYSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- NONWUQAWAANERO-BZSNNMDCSA-N Asp-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 NONWUQAWAANERO-BZSNNMDCSA-N 0.000 description 1
- QOCFFCUFZGDHTP-NUMRIWBASA-N Asp-Thr-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOCFFCUFZGDHTP-NUMRIWBASA-N 0.000 description 1
- BPAUXFVCSYQDQX-JRQIVUDYSA-N Asp-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)O)N)O BPAUXFVCSYQDQX-JRQIVUDYSA-N 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- LVRKAFPPFJRIOF-GARJFASQSA-N Gln-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N LVRKAFPPFJRIOF-GARJFASQSA-N 0.000 description 1
- FNAJNWPDTIXYJN-CIUDSAMLSA-N Gln-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O FNAJNWPDTIXYJN-CIUDSAMLSA-N 0.000 description 1
- QYPKJXSMLMREKF-BPUTZDHNSA-N Glu-Glu-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N QYPKJXSMLMREKF-BPUTZDHNSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- DTLLNDVORUEOTM-WDCWCFNPSA-N Glu-Thr-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DTLLNDVORUEOTM-WDCWCFNPSA-N 0.000 description 1
- QEJKKJNDDDPSMU-KKUMJFAQSA-N Glu-Tyr-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(O)=O QEJKKJNDDDPSMU-KKUMJFAQSA-N 0.000 description 1
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 1
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 1
- LXXANCRPFBSSKS-IUCAKERBSA-N Gly-Gln-Leu Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LXXANCRPFBSSKS-IUCAKERBSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- FCKPEGOCSVZPNC-WHOFXGATSA-N Gly-Ile-Phe Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FCKPEGOCSVZPNC-WHOFXGATSA-N 0.000 description 1
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 1
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 1
- BXDLTKLPPKBVEL-FJXKBIBVSA-N Gly-Thr-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O BXDLTKLPPKBVEL-FJXKBIBVSA-N 0.000 description 1
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 1
- DEOQGJUXUQGUJN-KKUMJFAQSA-N His-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DEOQGJUXUQGUJN-KKUMJFAQSA-N 0.000 description 1
- YVCGJPIKRMGNPA-LSJOCFKGSA-N His-Met-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O YVCGJPIKRMGNPA-LSJOCFKGSA-N 0.000 description 1
- PZUZIHRPOVVHOT-KBPBESRZSA-N His-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CN=CN1 PZUZIHRPOVVHOT-KBPBESRZSA-N 0.000 description 1
- BOTVMTSMOUSDRW-GMOBBJLQSA-N Ile-Arg-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O BOTVMTSMOUSDRW-GMOBBJLQSA-N 0.000 description 1
- JQLFYZMEXFNRFS-DJFWLOJKSA-N Ile-Asp-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N JQLFYZMEXFNRFS-DJFWLOJKSA-N 0.000 description 1
- MQFGXJNSUJTXDT-QSFUFRPTSA-N Ile-Gly-Ile Chemical compound N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)O MQFGXJNSUJTXDT-QSFUFRPTSA-N 0.000 description 1
- ADDYYRVQQZFIMW-MNXVOIDGSA-N Ile-Lys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ADDYYRVQQZFIMW-MNXVOIDGSA-N 0.000 description 1
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 1
- XHBYEMIUENPZLY-GMOBBJLQSA-N Ile-Pro-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O XHBYEMIUENPZLY-GMOBBJLQSA-N 0.000 description 1
- AGGIYSLVUKVOPT-HTFCKZLJSA-N Ile-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N AGGIYSLVUKVOPT-HTFCKZLJSA-N 0.000 description 1
- KBDIBHQICWDGDL-PPCPHDFISA-N Ile-Thr-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N KBDIBHQICWDGDL-PPCPHDFISA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 1
- IGUOAYLTQJLPPD-DCAQKATOSA-N Leu-Asn-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IGUOAYLTQJLPPD-DCAQKATOSA-N 0.000 description 1
- XBCWOTOCBXXJDG-BZSNNMDCSA-N Leu-His-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 XBCWOTOCBXXJDG-BZSNNMDCSA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- DRWMRVFCKKXHCH-BZSNNMDCSA-N Leu-Phe-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=CC=C1 DRWMRVFCKKXHCH-BZSNNMDCSA-N 0.000 description 1
- ADJWHHZETYAAAX-SRVKXCTJSA-N Leu-Ser-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ADJWHHZETYAAAX-SRVKXCTJSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 1
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 1
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 1
- 239000006391 Luria-Bertani Medium Substances 0.000 description 1
- LZWNAOIMTLNMDW-NHCYSSNCSA-N Lys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N LZWNAOIMTLNMDW-NHCYSSNCSA-N 0.000 description 1
- NDORZBUHCOJQDO-GVXVVHGQSA-N Lys-Gln-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O NDORZBUHCOJQDO-GVXVVHGQSA-N 0.000 description 1
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- PIXVFCBYEGPZPA-JYJNAYRXSA-N Lys-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N PIXVFCBYEGPZPA-JYJNAYRXSA-N 0.000 description 1
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 1
- NCVJJAJVWILAGI-SRVKXCTJSA-N Met-Gln-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N NCVJJAJVWILAGI-SRVKXCTJSA-N 0.000 description 1
- JKXVPNCSAMWUEJ-GUBZILKMSA-N Met-Met-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O JKXVPNCSAMWUEJ-GUBZILKMSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- HHOOEUSPFGPZFP-QWRGUYRKSA-N Phe-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HHOOEUSPFGPZFP-QWRGUYRKSA-N 0.000 description 1
- KLXQWABNAWDRAY-ACRUOGEOSA-N Phe-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 KLXQWABNAWDRAY-ACRUOGEOSA-N 0.000 description 1
- DBALDZKOTNSBFM-FXQIFTODSA-N Pro-Ala-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DBALDZKOTNSBFM-FXQIFTODSA-N 0.000 description 1
- FZHBZMDRDASUHN-NAKRPEOUSA-N Pro-Ala-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(O)=O FZHBZMDRDASUHN-NAKRPEOUSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- JMVQDLDPDBXAAX-YUMQZZPRSA-N Pro-Gly-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 JMVQDLDPDBXAAX-YUMQZZPRSA-N 0.000 description 1
- FKLSMYYLJHYPHH-UWVGGRQHSA-N Pro-Gly-Leu Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O FKLSMYYLJHYPHH-UWVGGRQHSA-N 0.000 description 1
- UREQLMJCKFLLHM-NAKRPEOUSA-N Pro-Ile-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UREQLMJCKFLLHM-NAKRPEOUSA-N 0.000 description 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 1
- 101000703650 Pseudoalteromonas carrageenovora Arylsulfatase Proteins 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- BPZMKEJXIKAZKN-UHFFFAOYSA-N S(=O)(=O)(O)O.[N+](=O)([O-])C1=CC=C(C=C1)[K] Chemical compound S(=O)(=O)(O)O.[N+](=O)([O-])C1=CC=C(C=C1)[K] BPZMKEJXIKAZKN-UHFFFAOYSA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- WEQAYODCJHZSJZ-KKUMJFAQSA-N Ser-His-Tyr Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 WEQAYODCJHZSJZ-KKUMJFAQSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- NMZXJDSKEGFDLJ-DCAQKATOSA-N Ser-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)O NMZXJDSKEGFDLJ-DCAQKATOSA-N 0.000 description 1
- YXEYTHXDRDAIOJ-CWRNSKLLSA-N Ser-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N)C(=O)O YXEYTHXDRDAIOJ-CWRNSKLLSA-N 0.000 description 1
- CTONFVDJYCAMQM-IUKAMOBKSA-N Thr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)N CTONFVDJYCAMQM-IUKAMOBKSA-N 0.000 description 1
- LXWZOMSOUAMOIA-JIOCBJNQSA-N Thr-Asn-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O LXWZOMSOUAMOIA-JIOCBJNQSA-N 0.000 description 1
- ZQUKYJOKQBRBCS-GLLZPBPUSA-N Thr-Gln-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O ZQUKYJOKQBRBCS-GLLZPBPUSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 1
- VTCKHZJKWQENKX-KBPBESRZSA-N Tyr-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O VTCKHZJKWQENKX-KBPBESRZSA-N 0.000 description 1
- DJIJBQYBDKGDIS-JYJNAYRXSA-N Tyr-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O DJIJBQYBDKGDIS-JYJNAYRXSA-N 0.000 description 1
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 description 1
- NWDOPHYLSORNEX-QXEWZRGKSA-N Val-Asn-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N NWDOPHYLSORNEX-QXEWZRGKSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- XBJKAZATRJBDCU-GUBZILKMSA-N Val-Pro-Ala Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O XBJKAZATRJBDCU-GUBZILKMSA-N 0.000 description 1
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 1
- GUIYPEKUEMQBIK-JSGCOSHPSA-N Val-Tyr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O GUIYPEKUEMQBIK-JSGCOSHPSA-N 0.000 description 1
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 108010077158 leucinyl-arginyl-tryptophan Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001132 ultrasonic dispersion Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域 technical field
本发明属于酶工程领域,尤其涉及利用羧基功能化磁性纳米颗粒固定化酶法辅助提取琼脂的方法。 The invention belongs to the field of enzyme engineering, in particular to a method for assisting the extraction of agar by using carboxyl functionalized magnetic nanoparticles to immobilize enzymes.
背景技术 Background technique
琼脂是一种来源于红藻类植物细胞壁的天然有机多糖胶体,在食品、医药、化工等领域应用广泛。琼脂是由琼脂糖(agarose)和琼脂胶(agaropectin)构成的混合物,并且以琼脂糖为主。琼脂糖是由(1-3)-β-D-半乳糖和(1-4)-3, 6-内醚-α-L-半乳糖等组成的链状聚合物,而琼脂胶的结构比较复杂,其主要结构与琼脂糖相同,只是(1-4)-3, 6-内醚-α-L-半乳糖上的羟基易被硫酸基、甲氧基、丙酮基等基团替代。相关研究表明,对琼脂进行脱硫酸基团处理可以有效提高琼脂的凝胶强度或生产高凝胶强度的琼脂糖,从而大幅度提高产品的应用价值。 Agar is a natural organic polysaccharide colloid derived from the cell wall of red algae. It is widely used in food, medicine, chemical industry and other fields. Agar is a mixture of agarose and agaropectin, with agarose as the main ingredient. Agarose is a chain polymer composed of (1-3)-β-D-galactose and (1-4)-3,6-inner ether-α-L-galactose, etc., and the structure of agarose gel is relatively It is complex, and its main structure is the same as that of agarose, except that the hydroxyl group on (1-4)-3, 6-inside ether-α-L-galactose is easily replaced by sulfate groups, methoxy groups, acetonyl groups and other groups. Relevant studies have shown that desulfurization treatment of agar can effectively improve the gel strength of agar or produce agarose with high gel strength, thereby greatly improving the application value of the product.
目前,脱除琼脂硫酸基团的主要方法为化学法,由于大量使用强碱进行处理脱除琼脂中的硫酸基团,需要加入大量的酸中和过量的碱,还要用大量的水漂洗去除盐,存在生产过程不容易控制、产品得率低、对环境污染大、工艺复杂等不足。相对于化学法,用酶法对琼脂进行改性具有反应条件温和、底物转化率高、无污染、工艺简便等优点。因此,芳香基硫酸酯酶辅助提取琼胶将逐渐取代传统的化学等降解方法成为制备琼脂的最佳方法。然而,目前对芳香基硫酸酯酶作用于琼脂的研究工作还很不充分且存在酶活不高、纯化步骤繁琐等问题,这制约着利用芳香基硫酸酯酶改性琼脂生产高附加值产品的应用与开发。有鉴于此,本发明人研究和设计了一种固定化重组芳香基硫酸酯酶的方法及其应用办法,本案由此产生。 At present, the main method for removing sulfuric acid groups in agar is chemical method. Since a large amount of strong alkali is used to remove the sulfuric acid groups in agar, it is necessary to add a large amount of acid to neutralize the excess alkali, and to rinse with a large amount of water to remove it. Salt has the disadvantages that the production process is not easy to control, the product yield is low, the environment is polluted, and the process is complicated. Compared with chemical methods, enzymatic modification of agar has the advantages of mild reaction conditions, high substrate conversion rate, no pollution, and simple process. Therefore, arylsulfatase-assisted extraction of agar will gradually replace traditional chemical degradation methods and become the best method for preparing agar. However, the current research on the effect of arylsulfatase on agar is still insufficient and there are problems such as low enzyme activity and cumbersome purification steps, which restrict the use of arylsulfatase to modify agar to produce high value-added products. application and development. In view of this, the inventors researched and designed a method for immobilizing recombinant arylsulfatase and its application method, and this case arose from it.
发明内容 Contents of the invention
本发明的第一个目的是提供一种芳香基硫酸酯酶基因atsA。 The first object of the present invention is to provide an arylsulfatase gene atsA .
本发明的第二个目的是提供一种由所述芳香基硫酸酯酶基因atsA编码的重组芳香基硫酸酯酶。 The second object of the present invention is to provide a recombinant arylsulfatase encoded by the arylsulfatase gene atsA .
本发明的第三个目的是提供一种所述重组芳香基硫酸酯酶的制备方法。 The third object of the present invention is to provide a preparation method of the recombinant arylsulfatase.
本发明的第四个目的是提供一种羧基功能化磁性纳米颗粒固定化所述游离重组芳香基硫酸酯酶的方法。 The fourth object of the present invention is to provide a method for immobilizing the free recombinant arylsulfatase with carboxyl-functionalized magnetic nanoparticles.
本发明的第五个目的是提供一种所述游离重组芳香基硫酸酯酶和固定化重组芳香基硫酸酯酶在降解琼脂中的硫酸基团的应用。 The fifth object of the present invention is to provide an application of the free recombinant arylsulfatase and the immobilized recombinant arylsulfatase in degrading sulfate groups in agar.
为实现上述目的,本发明解决其技术问题的技术方案是: In order to achieve the above object, the technical solution of the present invention to solve its technical problems is:
食鹿角菜假交替单胞菌(Pseudoalteromonas carrageenovora sp. ASY5),该菌株来源于中国工业微生物菌种保藏管理中心(CICC),保藏编号:CICC 23819。 Pseudoalteromonas carrageenonovora sp. ASY5, the strain comes from the China Center for Industrial Microorganism Culture Collection (CICC), and the preservation number is CICC 23819.
一种从食鹿角菜假交替单胞菌CICC 23819中分离得到的芳香基硫酸酯酶基因atsA,其核苷酸序列如SEQ ID NO.1所示。 An arylsulfatase gene ats A isolated from Pseudoalteromonas carrageenans CICC 23819, the nucleotide sequence of which is shown in SEQ ID NO.1.
一种芳香基硫酸酯酶基因atsA编码的芳香基硫酸酯酶,其氨基酸序列如SEQ ID NO.2所示。 An aryl sulfatase encoded by the aryl sulfatase gene ats A, the amino acid sequence of which is shown in SEQ ID NO.2.
一种重组芳香基硫酸酯酶的制备方法,包括以下步骤: A preparation method for recombinant arylsulfatase, comprising the following steps:
步骤一:从食鹿角菜假交替单胞菌(Pseudoalteromonas carrageenovora sp.)ASY5中克隆芳香基硫酸酯酶基因atsA; Step 1: Cloning the arylsulfatase gene ats A from Pseudoalteromonas carrageenovora sp. ASY5;
步骤二:将所述芳香基硫酸酯酶基因atsA插入pET-28a(+)载体构建重组质粒; Step 2: inserting the arylsulfatase gene ats A into the pET-28a(+) vector to construct a recombinant plasmid;
步骤三:将所述重组质粒转化到大肠杆菌(E. coli) BL21 (DE3)中;挑选阳性克隆在Luria-Bertani培养基中培养,所述Luria-Bertani培养基含50 μg/mL的卡那霉素,培养条件为温度37°C,摇床培养至OD 600=0.8时,再加入异丙基硫代-β-D-半乳糖苷(IPTG)至终浓度为50 mmol/L,在15°C条件下诱导26 h; Step 3: Transform the recombinant plasmid into Escherichia coli ( E. coli ) BL21 (DE3); select positive clones and cultivate them in Luria-Bertani medium containing 50 μg/mL of Kanna Mycin, the culture condition is temperature 37°C, shaker culture to OD 600 =0.8, then add isopropylthio-β-D-galactoside (IPTG) to the final concentration of 50 mmol/L, at 15 Induce for 26 h at °C;
步骤四:离心收集发酵后的E. coli BL 21 (DE3)菌体,重悬沉淀于溶解缓冲液中利用超声波破壁裂解;所述溶解缓冲液的配方可为:50mmol/L NaH2PO4,300mmol/L NaCl,15 mmol/L咪唑,pH 8.0; Step 4: Collect the fermented E. coli BL 21 (DE3) cells by centrifugation, resuspend the pellet in the lysis buffer and lyse it with ultrasonic waves; the formula of the lysis buffer can be: 50mmol/L NaH 2 PO 4 , 300mmol/L NaCl, 15 mmol/L imidazole, pH 8.0;
步骤五:将步骤四中裂解后的悬浊液于4°C,15000×g条件下,冷冻离心20 min后,收集上清液,与Ni-NTA Agarose 混匀,进行纯化,即得所述重组芳香基硫酸酯酶。 Step 5: Put the lysed suspension in step 4 at 4°C and 15000×g for 20 min, collect the supernatant, mix with Ni-NTA Agarose, and purify to obtain the Recombinant arylsulfatase.
一种重组芳香基硫酸酯酶的固定化方法,包括以下步骤: A method for immobilizing recombinant arylsulfatase, comprising the following steps:
步骤一:利用化学共沉淀法制备羧基功能化的磁性纳米粒子:Fe3+和Fe2+溶液混合,在剧烈搅拌条件下快速加入氨水,1分钟后,逐滴加入油酸,70°C下继续快速搅拌,反应结束后,得到黑色溶胶状物质,用外加磁场将所得的沉淀从反应体系中分离出来,用乙醇、离子水洗涤,然后加入KMnO4溶液,超声波清洗仪超声振荡,磁分离后用去离子水洗涤得磁流体,真空冷冻干燥所述磁流体,制得表面修饰有羧基的磁性纳米粒子; Step 1: Preparation of carboxyl-functionalized magnetic nanoparticles by chemical co-precipitation method: Fe 3+ and Fe 2+ solutions were mixed, ammonia water was quickly added under vigorous stirring conditions, and oleic acid was added dropwise after 1 minute, at 70°C Continue to stir rapidly. After the reaction is over, a black sol-like substance is obtained. Use an external magnetic field to separate the resulting precipitate from the reaction system, wash with ethanol and ion water, then add KMnO 4 solution, and ultrasonically oscillate with an ultrasonic cleaner. After magnetic separation Washing with deionized water to obtain a magnetic fluid, and vacuum freeze-drying the magnetic fluid to prepare magnetic nanoparticles with carboxyl groups on the surface;
步骤二:固定化重组芳香基硫酸酯酶:取10 mg磁性纳米载体,经超声分散后加入5ml体积百分比为1.0%的戊二醛溶液,4°C振荡3h后,用50 mM pH 7.0 Tris-HCl缓冲液冲洗交联载体;加入30 μL 重组芳香基硫酸酯酶液,磁性纳米载体与游离芳香基硫酸酯酶的比为1mg:0.7U;低温固定化,固定化时间3h,温度为4℃;之后用Tris-HCl缓冲液冲洗,真空冷冻干燥得固定化酶。 Step 2: Immobilization of recombinant arylsulfatase: take 10 mg of magnetic nanocarriers, ultrasonically disperse them, add 5 ml of 1.0% by volume glutaraldehyde solution, shake at 4°C for 3 hours, and wash with 50 mM pH 7.0 Tris- Wash the cross-linked carrier with HCl buffer; add 30 μL recombinant aryl sulfatase solution, the ratio of magnetic nanocarriers to free aryl sulfatase is 1mg:0.7U; immobilize at low temperature, the immobilization time is 3h, and the temperature is 4°C ; Afterwards, wash with Tris-HCl buffer solution and vacuum freeze-dry to obtain immobilized enzyme.
作为实施例的优选方式,在所述步骤二中,所述游离重组芳香基硫酸酯酶液为大肠杆菌细胞经过超声波破壁后低温高速离心所得上清液。 As a preferred embodiment of the embodiment, in the second step, the free recombinant arylsulfatase solution is the supernatant obtained by centrifuging Escherichia coli cells at low temperature and high speed after the cells are broken by ultrasonic waves.
一种游离重组芳香基硫酸酯酶和固定化重组芳香基硫酸酯酶分别在降解琼脂中的硫酸基团的应用。 The application of a free recombinant arylsulfatase and an immobilized recombinant arylsulfatase to degrade sulfuric acid groups in agar respectively.
本发明采用上述技术方案后,芳香基硫酸酯酶能够在E. coli中稳定表达,并且纯化后的酶活力高,克服了现有芳香基硫酸酯酶活力低,酶分离纯化过程繁琐等问题,而重组表达的芳香基硫酸酯酶对琼胶中的SO42-具有很好的降解作用,在琼胶提取生产过程中可替代或部分替代碱处理,从而减少污染,节约水资源。 After the above-mentioned technical scheme is adopted in the present invention, the arylsulfatase can be stably expressed in E. coli , and the enzyme activity after purification is high, which overcomes the problems of low activity of the existing arylsulfatase and cumbersome enzyme separation and purification process, etc. The recombinantly expressed arylsulfatase has a good degradation effect on SO4 2- in agar, and can replace or partially replace alkali treatment in the process of agar extraction and production, thereby reducing pollution and saving water resources.
附图说明 Description of drawings
图1: Pseudoalteromonas carrageenovora芳香基硫酸酯酶基因在大肠杆菌中的表达纯化的SDS-PAGE图;其中,M为蛋白标准Marker,1泳道为质粒pET-28a(+)在E. coli BL21 (DE3)中的表达(诱导);2泳道为重组质粒在E. coli BL21 (DE3)中的诱导表达;3泳道为重组质粒在E. coli BL21 (DE3)中的表达(未诱导);4泳道为经Ni-NTA纯化所得的目的蛋白,分子量为35.1 kDa; Figure 1: SDS-PAGE diagram of expression and purification of Pseudoalteromonas carrageenovora arylsulfatase gene in Escherichia coli; among them, M is the protein standard marker, and lane 1 is the plasmid pET-28a(+) in E. coli BL21 (DE3) Expression in E. coli BL21 (DE3) in lane 2 (induction); Lane 2 is the expression of recombinant plasmid in E. coli BL21 (DE3); Lane 3 is the expression of recombinant plasmid in E. coli BL21 (DE3) (not induced); Lane 4 is the expression of The target protein purified by Ni-NTA has a molecular weight of 35.1 kDa;
图2:固定化重组芳香基硫酸酯酶操作重复性的考察。 Figure 2: Investigation of the repeatability of the immobilized recombinant arylsulfatase operation.
具体实施方式 Detailed ways
下列实施例中采用的检测方法:The detection method adopted in the following examples:
重组芳香基硫酸酯酶活性的测定:反应体系包括80 μL 20 mmol/L对硝基苯硫酸钾(p-NPS,以50 mmol/L Tris-HCl (pH 7.0)缓冲液配制),20 μL酶液(浓度为6 μg/mL),在50°C温育10 min后,加入25 μL 1 mol/L NaOH终止反应,以预冷蒸馏水补足体积至1 mL,在410 nm下测定吸收值。芳香基硫酸酯酶的活力(U)定义为:在上述条件下,每分钟催化生成1 μmoL对硝基苯酚(p-NP)所需的酶量。 Determination of recombinant arylsulfatase activity: the reaction system included 80 μL 20 mmol/L p-nitrophenyl potassium sulfate (p-NPS, prepared with 50 mmol/L Tris-HCl (pH 7.0) buffer), 20 μL enzyme After incubation at 50°C for 10 min, 25 μL of 1 mol/L NaOH was added to terminate the reaction, the volume was made up to 1 mL with pre-cooled distilled water, and the absorbance was measured at 410 nm. The activity (U) of arylsulfatase is defined as: under the above conditions, the amount of enzyme required to catalyze the generation of 1 μmoL p-nitrophenol (p-NP) per minute.
硫酸基含量的测定:0.5 mL酶液与1 mL 0.2%琼脂溶液在50°C振摇反应1 h,后离心取0.9 mL上清液,再加入0.2 mL 浓HCl和0.6 mL 13.3%氯化钡-2.67%Tween-80溶液,混匀,室温静置30 min,在420 nm波长处测定吸光值。 Determination of sulfate group content: 0.5 mL enzyme solution and 1 mL 0.2% agar solution were shaken at 50°C for 1 h, then centrifuged to get 0.9 mL supernatant, then added 0.2 mL concentrated HCl and 0.6 mL 13.3% barium chloride -2.67% Tween-80 solution, mix well, let it stand at room temperature for 30 min, and measure the absorbance at a wavelength of 420 nm.
凝胶强度的测定:配制1.5%的琼脂溶液,完全溶解后在室温下放置15 h,制备好的样品放在凝胶强度测定仪的试样座中心位置上,按凝胶强度测定仪说明书进行操作,移动手柄使砝码添加装置杆下端与凝胶表面接触,加大力度使凝胶的表面发生破裂(端点进入凝胶约4mm以上),记录此时凝胶强度值。 Determination of gel strength: prepare 1.5% agar solution, and place it at room temperature for 15 hours after completely dissolving, place the prepared sample on the center of the sample seat of the gel strength tester, and follow the instructions of the gel strength tester Operation, move the handle to make the lower end of the weight adding device rod contact the surface of the gel, increase the force to break the surface of the gel (the end point enters the gel by about 4mm or more), record the value of the gel strength at this time.
实施例1:芳香基硫酸酯酶基因的扩增与克隆Embodiment 1: Amplification and cloning of arylsulfatase gene
芳香基硫酸酯酶基因的正向引物序列为:5’-CGCGGATCCCAAAAAATTAGTATTAT-3’ (下划线为BamH I识别序列),反向引物序列为: 5’-CCCAAGCTTGCGTTTTAGTTCGTAAC-3’ (下划线为Hind III识别序列)。以Pseudoalteromonas carrageenovora基因组DNA为模板,进行芳香基硫酸酯酶基因扩增。 The forward primer sequence of the arylsulfatase gene is: 5'-CGC GGATCC CAAAAAATTAGTATTAT-3' (the underline is the Bam HI recognition sequence), and the reverse primer sequence is: 5'-CCC AAGCTT GCGTTTTAGTTCGTAAC-3' (the underline is the Hin d III recognition sequence). The arylsulfatase gene was amplified using Pseudoalteromonas carrageenonovora genomic DNA as a template.
扩增反应程序: 95°C预变性3 min,94°C变性1 min,55°C退火45 s,72°C延伸1 min,30次循环;72°C 10 min。琼脂糖凝胶电泳检测PCR产物的大小,纯化后的PCR产物与pMD18-T载体连接,连接产物转化E. coli DH5α感受态细胞。细胞涂布在LB培养平板(含100 μg/mL氨苄青霉素)上,经菌落PCR鉴定后,测序鉴定目的基因序列,具体核苷酸序列和氨基酸序列示于GenBank登录号KJ509595。 Amplification reaction program: pre-denaturation at 95°C for 3 min, denaturation at 94°C for 1 min, annealing at 55°C for 45 s, extension at 72°C for 1 min, 30 cycles; 72°C for 10 min. The size of the PCR product was detected by agarose gel electrophoresis, the purified PCR product was ligated with the pMD18-T vector, and the ligated product was transformed into E. coli DH5α competent cells. The cells were smeared on LB culture plates (containing 100 μg/mL ampicillin). After colony PCR identification, the target gene sequence was identified by sequencing. The specific nucleotide sequence and amino acid sequence are shown in GenBank accession number KJ509595.
实施例2:芳香基硫酸酯酶的提取Embodiment 2: the extraction of arylsulfatase
将含有芳香基硫酸酯酶基因的重组质粒pET-28a(+)转化至感受态细胞E. coli BL21(DE3),在含有50 μg/mL卡那霉素的LB平板培养基上37°C培养12 h,挑选阳性克隆单菌落于5 mL LB液体培养基(含50 μg/mL卡那霉素),37°C培养至OD 600=0.8时,再加入异丙基硫代-β-D-半乳糖苷(IPTG)至终浓度为50 mmol/L,在15°C条件下诱导26 h,离心收集菌体,悬浮于200 mL 50 mM pH 7.0 Tris-HCl缓冲液中,用超声波裂解细菌细胞。4°C 15000×g离心20 min收集上清液,即为芳香基硫酸酯酶粗酶液。采用SDS-PAGE技术,分析芳香基硫酸酯酶基因在大肠杆菌中的表达纯化情况,结果如图1所示。 Transform the recombinant plasmid pET-28a(+) containing the arylsulfatase gene into competent cells E. coli BL21(DE3), culture on LB plate medium containing 50 μg/mL kanamycin at 37°C After 12 h, select a single colony of the positive clone and culture it in 5 mL LB liquid medium (containing 50 μg/mL kanamycin) at 37°C until OD 600 =0.8, then add isopropylthio-β-D- Galactoside (IPTG) to a final concentration of 50 mmol/L, induced at 15°C for 26 h, collected by centrifugation, suspended in 200 mL of 50 mM pH 7.0 Tris-HCl buffer, and lysed by ultrasonic waves . Centrifuge at 15,000×g for 20 min at 4°C to collect the supernatant, which is the crude enzyme solution of arylsulfatase. The SDS-PAGE technique was used to analyze the expression and purification of the arylsulfatase gene in E. coli, and the results are shown in Figure 1.
实施例3:羧基功能化磁性纳米颗粒的制备Example 3: Preparation of Carboxyl Functionalized Magnetic Nanoparticles
FeCl3·6H2O溶液和FeCl2·4H2O溶液混合,在剧烈搅拌条件下快速加入氨水,1分钟后,逐滴加入油酸,70°C下继续快速搅拌1小时。反应结束后,得到黑色溶胶状物质,用外加磁场将所得的沉淀从反应体系中分离出来。用乙醇洗2遍除去多余的油酸,再用去离子水洗涤至pH=7左右。然后加入KMnO4溶液,超声波清洗仪超声振荡8 h,磁分离后用去离子水洗涤3次,得到磁流体。真空冷冻干燥24 h,得到表面修饰有羧基的磁性纳米粒子。 FeCl 3 ·6H 2 O solution and FeCl 2 ·4H 2 O solution were mixed, ammonia water was quickly added under vigorous stirring, and oleic acid was added dropwise after 1 minute, and rapid stirring was continued for 1 hour at 70°C. After the reaction, a black sol-like substance was obtained, and the resulting precipitate was separated from the reaction system by applying an external magnetic field. Wash with ethanol twice to remove excess oleic acid, and then wash with deionized water to about pH=7. Then add the KMnO 4 solution, ultrasonically oscillate for 8 h with an ultrasonic cleaner, and wash with deionized water three times after magnetic separation to obtain a magnetic fluid. Vacuum freeze-drying for 24 h to obtain magnetic nanoparticles with surface-modified carboxyl groups.
实施例4:重组芳香基硫酸酯酶的固定化Example 4: Immobilization of recombinant arylsulfatase
准确称取10 mg磁性纳米载体,经超声分散后加入体积百分比为1.0%的戊二醛溶液5ml,4°C振荡3h后,用50 mM pH 7.0 Tris-HCl缓冲液冲洗交联载体;加入30 μL (0.27 mg/mL)重组芳香基硫酸酯酶液,载体与游离芳香基硫酸酯酶的比为1mg:0.7U;低温固定化,固定化时间3h,温度为4℃;之后用Tris-HCl缓冲液冲洗,真空冷冻干燥得固定化酶。 Accurately weigh 10 mg of magnetic nanocarriers, add 5ml of glutaraldehyde solution with a volume percentage of 1.0% after ultrasonic dispersion, shake at 4°C for 3 hours, wash the cross-linked carrier with 50 mM pH 7.0 Tris-HCl buffer solution; add 30 μL (0.27 mg/mL) recombinant arylsulfatase solution, the ratio of carrier to free arylsulfatase is 1mg:0.7U; immobilized at low temperature, the immobilization time is 3h, the temperature is 4℃; after that, use Tris-HCl The buffer was washed, and the immobilized enzyme was vacuum freeze-dried.
实施例5:固定化重组芳香基硫酸酯酶的操作重复性Example 5: Operation repeatability of immobilized recombinant arylsulfatase
按照芳香基硫酸酯酶活力的测定方法测定固定化酶活力,磁分离后的固定化酶用50mM pH 7.0 Tris-HCl缓冲液清洗3次,继续测定固定化酶活力,重复操作9次,结果如图2所示。 Measure immobilized enzyme activity according to the mensuration method of arylsulfatase activity, the immobilized enzyme after magnetic separation washes 3 times with 50mM pH 7.0 Tris-HCl buffer solution, continues to measure immobilized enzyme activity, repeats operation 9 times, the result is as follows Figure 2 shows.
实施例6:固定化重组芳香基硫酸酯酶脱除琼脂硫酸基团Example 6: Immobilized recombinant arylsulfatase removes agar sulfate group
利用游离重组芳香基硫酸酯酶和固定化重组芳香基硫酸酯酶分别处理琼脂,测定硫酸基团含量、凝胶强度决定琼胶产品质量的关键因素。 The agar was treated with free recombinant arylsulfatase and immobilized recombinant arylsulfatase respectively, and the content of sulfuric acid group and gel strength were determined as the key factors to determine the quality of agar products.
游离酶处理组:取1 mL 0.2%的琼脂溶液,加入50 U(0.5 mL)游离芳香基硫酸酯酶,40°C振摇1 h,测定产物的硫酸基团含量、凝胶强度。 Free enzyme treatment group: take 1 mL of 0.2% agar solution, add 50 U (0.5 mL) of free arylsulfatase, shake at 40°C for 1 h, and measure the sulfate group content and gel strength of the product.
固定化酶处理组:取1 mL 0.2%的琼脂溶液,加入50 U(25 mg)固定化芳香基硫酸酯酶,40°C振摇1 h,测定产物的硫酸基团含量、凝胶强度。 Immobilized enzyme treatment group: Take 1 mL of 0.2% agar solution, add 50 U (25 mg) of immobilized arylsulfatase, shake at 40°C for 1 h, and measure the sulfate group content and gel strength of the product.
空白组:取1 mL 0.2%的琼脂溶液,加入0.5 mL蒸馏水,40°C振摇1 h,测定产物的硫酸基团含量、凝胶强度。测定结果见表1(现场温度为28°C,温度校正系数为1.27)。 Blank group: Take 1 mL of 0.2% agar solution, add 0.5 mL of distilled water, shake at 40°C for 1 h, and measure the content of sulfate groups and gel strength of the product. The measurement results are shown in Table 1 (the site temperature is 28°C, and the temperature correction coefficient is 1.27).
表1 Table 1
无论是游离芳香基硫酸酯酶还是固定化芳香基硫酸酯酶均能脱除琼脂中的硫酸基团,并提高所得琼脂的凝胶强度,由于固定化芳香基硫酸酯酶可以反复利用,分离简单,且产品质量稳定,在琼脂生产工艺中具有良好的应用价值。 Both free aryl sulfatase and immobilized aryl sulfatase can remove sulfate groups in agar and improve the gel strength of the agar obtained. Since the immobilized aryl sulfatase can be used repeatedly, the separation is simple , and the product quality is stable, and has good application value in the agar production process.
本领域的普通技术人员能从本发明公开内容直接导出或联想到的所有变形,均应认为是本发明的保护范围。 All deformations that can be derived or associated directly from the disclosure content of the present invention by those skilled in the art should be considered as the protection scope of the present invention.
序列表 sequence listing
the
<110> 集美大学 <110> Jimei University
<120> 一种芳香基硫酸酯酶基因、编码蛋白及其固定化的方法和应用 <120> A method and application of arylsulfatase gene, encoded protein and its immobilization
<130> 2015 <130> 2015
<160> 2 <160> 2
<170> PatentIn version 3.3 <170> PatentIn version 3.3
the
<210> 1 <210> 1
<211> 987 <211> 987
<212> DNA <212> DNA
<213> 食鹿角菜假交替单胞菌(Pseudoalteromonas carrageenovora sp.)ASY5 <213> Pseudoalteromonas carrageenovora sp. ASY5
the
<400> 1 <400> 1
atgcaaaaaa ttagtattat atttaattta tttctatctc taggctgttt agcatttacg 60 atgcaaaaaa ttagtattat atttaattta tttctatctc taggctgttt agcatttacg 60
the
tttaacggca gcgcaagcga aacaaaaaat gagtggataa ctctaggtac gatggcaggc 120 tttaacggca gcgcaagcga aacaaaaaat gagtggataa ctctaggtac gatggcaggc 120
the
cctattccta atgcaaaaca ctctcaacca gctaatgcga tgcttgttaa tggcaatacg 180 cctattccta atgcaaaaca ctctcaacca gctaatgcga tgcttgttaa tggcaatacg 180
the
tatgtggttg atgccggtga cggaactgca gggcaattag caaaagttgg gttagacata 240 tatgtggttg atgccggtga cggaactgca gggcaattag caaaagttgg gttagacata 240
the
aaaaatgtcg atgcagtctt tttaagtcac ttacattttg accatacagg tggtttacct 300 aaaaatgtcg atgcagtctt tttaagtcac ttacattttg accatacagg tggtttacct 300
the
gcaattttga gtttaaggtg gcaaacaagc gcgcgtaatg agcttgttgt atatggccct 360 gcaattttga gtttaaggtg gcaaacaagc gcgcgtaatg agcttgttgt atatggccct 360
the
ccgggaactc agcaaaccgt tgatggtatt tttgaataca tgacttatgg cacgcttgga 420 ccgggaactc agcaaaccgt tgatggtatt tttgaataca tgacttatgg cacgcttgga 420
the
cactacggtg taccaggcca agttcctgcg cccgctaata ctaatatcaa agttgttgag 480 cactacggtg taccaggcca agttcctgcg cccgctaata ctaatatcaa agttgttgag 480
the
gttgaagatg ggactcaatt aaaacttcca gacttcactg tggatgttat aagaaactca 540 gttgaagatg ggactcaatt aaaacttcca gacttcactg tggatgttat aagaaactca 540
the
cactacagct ggccaaaagg aagtgaagag tggaaaaagt ttcaagcact ttcatttaaa 600 cactacagct ggccaaaagg aagtgaagag tggaaaaagt ttcaagcact ttcatttaaa 600
the
tttagtctac aagattatac agttgtttat acaggtgata cgggcccaag tagtgcagtt 660 tttagtctac aagattatac agttgtttat acaggtgata cgggcccaag tagtgcagtt 660
the
gagaagctat ctagcggtgt tgatttatta gtaagtgaga tgatggatat tgatcacaca 720 gagaagctat ctagcggtgt tgattatta gtaagtgaga tgatggatat tgatcacaca 720
the
gtcaacatga taaaagaaac aaaccctcaa atgcctaagg gtaagtttat tggcattcat 780 gtcaacatga taaaagaaac aaaccctcaa atgcctaagg gtaagtttat tggcattcat 780
the
aaacatcttt cgaagcacca cctttcacca aaacaagttg gtgagttagc taaagcagcc 840 aaacatcttt cgaagcacca cctttcacca aaacaagttg gtgagttagc taaagcagcc 840
the
aatgtaggca gtttagttat tactcatatg gcaccggggt tagatactca agccgaaata 900 aatgtaggca gtttagttat tactcatatg gcaccggggt tagatactca agccgaaata 900
the
gacttttata ctaaacaagt tgcaagtgaa tacaaagggc cgatctcagt agcacaagat 960 gacttttata ctaaacaagt tgcaagtgaa tacaaagggc cgatctcagt agcacaagat 960
the
ttaaaccgtt acgaactaaa acgctga 987 ttaaaccgtt acgaactaaa acgctga 987
the
the
<210> 2 <210> 2
<211> 328 <211> 328
<212> PRT <212> PRT
<213> 人工序列 <213> Artificial sequence
the
<400> 2 <400> 2
the
Met Gln Lys Ile Ser Ile Ile Phe Asn Leu Phe Leu Ser Leu Gly Cys Met Gln Lys Ile Ser Ile Ile Phe Asn Leu Phe Leu Ser Leu Gly Cys
the
Leu Ala Phe Thr Phe Asn Gly Ser Ala Ser Glu Thr Lys Asn Glu Trp Leu Ala Phe Thr Phe Asn Gly Ser Ala Ser Glu Thr Lys Asn Glu Trp
the
Ile Thr Leu Gly Thr Met Ala Gly Pro Ile Pro Asn Ala Lys His Ser Ile Thr Leu Gly Thr Met Ala Gly Pro Ile Pro Asn Ala Lys His Ser
`` ``
Gln Pro Ala Asn Ala Met Leu Val Asn Gly Asn Thr Tyr Val Val Asp Gln Pro Ala Asn Ala Met Leu Val Asn Gly Asn Thr Tyr Val Val Asp
the
Ala Gly Asp Gly Thr Ala Gly Gln Leu Ala Lys Val Gly Leu Asp Ile Ala Gly Asp Gly Thr Ala Gly Gln Leu Ala Lys Val Gly Leu Asp Ile
the
Lys Asn Val Asp Ala Val Phe Leu Ser His Leu His Phe Asp His Thr Lys Asn Val Asp Ala Val Phe Leu Ser His Leu His Phe Asp His Thr
``
Gly Gly Leu Pro Ala Ile Leu Ser Leu Arg Trp Gln Thr Ser Ala Arg Gly Gly Leu Pro Ala Ile Leu Ser Leu Arg Trp Gln Thr Ser Ala Arg
Asn Glu Leu Val Val Tyr Gly Pro Pro Gly Thr Gln Gln Thr Val Asp Asn Glu Leu Val Val Tyr Gly Pro Pro Gly Thr Gln Gln Thr Val Asp
``
Gly Ile Phe Glu Tyr Met Thr Tyr Gly Thr Leu Gly His Tyr Gly Val Gly Ile Phe Glu Tyr Met Thr Tyr Gly Thr Leu Gly His Tyr Gly Val
``
Pro Gly Gln Val Pro Ala Pro Ala Asn Thr Asn Ile Lys Val Val Glu Pro Gly Gln Val Pro Ala Pro Ala Asn Thr Asn Ile Lys Val Val Glu
the
Val Glu Asp Gly Thr Gln Leu Lys Leu Pro Asp Phe Thr Val Asp Val Val Glu Asp Gly Thr Gln Leu Lys Leu Pro Asp Phe Thr Val Asp Val
Ile Arg Asn Ser His Tyr Ser Trp Pro Lys Gly Ser Glu Glu Trp Lys Ile Arg Asn Ser His Tyr Ser Trp Pro Lys Gly Ser Glu Glu Trp Lys
Lys Phe Gln Ala Leu Ser Phe Lys Phe Ser Leu Gln Asp Tyr Thr Val Lys Phe Gln Ala Leu Ser Phe Lys Phe Ser Leu Gln Asp Tyr Thr Val
Val Tyr Thr Gly Asp Thr Gly Pro Ser Ser Ala Val Glu Lys Leu Ser Val Tyr Thr Gly Asp Thr Gly Pro Ser Ser Ala Val Glu Lys Leu Ser
Ser Gly Val Asp Leu Leu Val Ser Glu Met Met Asp Ile Asp His Thr Ser Gly Val Asp Leu Leu Val Ser Glu Met Met Asp Ile Asp His Thr
the
Val Asn Met Ile Lys Glu Thr Asn Pro Gln Met Pro Lys Gly Lys Phe Val Asn Met Ile Lys Glu Thr Asn Pro Gln Met Pro Lys Gly Lys Phe
`` ``
Ile Gly Ile His Lys His Leu Ser Lys His His Leu Ser Pro Lys Gln Ile Gly Ile His Lys His Leu Ser Lys His His Leu Ser Pro Lys Gln
the
Val Gly Glu Leu Ala Lys Ala Ala Asn Val Gly Ser Leu Val Ile Thr Val Gly Glu Leu Ala Lys Ala Ala Asn Val Gly Ser Leu Val Ile Thr
the
His Met Ala Pro Gly Leu Asp Thr Gln Ala Glu Ile Asp Phe Tyr Thr His Met Ala Pro Gly Leu Asp Thr Gln Ala Glu Ile Asp Phe Tyr Thr
the
Lys Gln Val Ala Ser Glu Tyr Lys Gly Pro Ile Ser Val Ala Gln Asp Lys Gln Val Ala Ser Glu Tyr Lys Gly Pro Ile Ser Val Ala Gln Asp
the
Leu Asn Arg Tyr Glu Leu Lys Arg Leu Asn Arg Tyr Glu Leu Lys Arg
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510084197.6A CN104630248A (en) | 2015-02-16 | 2015-02-16 | Aryl sulfatase gene, protein encoded by aryl sulfatase gene as well as immobilization method and application of protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510084197.6A CN104630248A (en) | 2015-02-16 | 2015-02-16 | Aryl sulfatase gene, protein encoded by aryl sulfatase gene as well as immobilization method and application of protein |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104630248A true CN104630248A (en) | 2015-05-20 |
Family
ID=53209494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510084197.6A Pending CN104630248A (en) | 2015-02-16 | 2015-02-16 | Aryl sulfatase gene, protein encoded by aryl sulfatase gene as well as immobilization method and application of protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104630248A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104946617A (en) * | 2015-06-10 | 2015-09-30 | 中国科学院福建物质结构研究所 | Method for preparing cross-link alkyl sulfatase aggregate |
CN105219748A (en) * | 2015-10-10 | 2016-01-06 | 集美大学 | A kind of fermentation process of Escherichia coli fermentation Restruction arylsulfatase |
CN106399334A (en) * | 2016-08-05 | 2017-02-15 | 集美大学 | Thermally stable mutant aromatic sulfatase and its gene and use |
CN110257439A (en) * | 2019-06-28 | 2019-09-20 | 集美大学 | A method of bio-ethanol is prepared using enzymatic treatment algal polysaccharides |
CN110564791A (en) * | 2019-08-20 | 2019-12-13 | 集美大学 | Modified agar powder |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101177678A (en) * | 2006-11-09 | 2008-05-14 | 中国科学院大连化学物理研究所 | A magnetic nanoparticle-immobilized enzyme and its preparation method and application |
CN101503683A (en) * | 2009-03-13 | 2009-08-12 | 华东理工大学 | Magnetic nano particle immobilized Serratieae lipase, preparation and use |
CN102703418A (en) * | 2012-07-02 | 2012-10-03 | 西南石油大学 | Preparation method of magnetic chitosan microsphere immobilized horse radish peroxidases |
CN103352045A (en) * | 2013-06-28 | 2013-10-16 | 国家海洋局第三海洋研究所 | Arylsulfatase and preparation method and applications thereof |
-
2015
- 2015-02-16 CN CN201510084197.6A patent/CN104630248A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101177678A (en) * | 2006-11-09 | 2008-05-14 | 中国科学院大连化学物理研究所 | A magnetic nanoparticle-immobilized enzyme and its preparation method and application |
CN101503683A (en) * | 2009-03-13 | 2009-08-12 | 华东理工大学 | Magnetic nano particle immobilized Serratieae lipase, preparation and use |
CN102703418A (en) * | 2012-07-02 | 2012-10-03 | 西南石油大学 | Preparation method of magnetic chitosan microsphere immobilized horse radish peroxidases |
CN103352045A (en) * | 2013-06-28 | 2013-10-16 | 国家海洋局第三海洋研究所 | Arylsulfatase and preparation method and applications thereof |
Non-Patent Citations (1)
Title |
---|
YIN Q ET AL.: "Pseudoalteromonas carrageenovora strain Ary987 arylsulfatase (atsA) gene, complete cds,GenBank: KJ509595.1", 《GENBANK》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104946617A (en) * | 2015-06-10 | 2015-09-30 | 中国科学院福建物质结构研究所 | Method for preparing cross-link alkyl sulfatase aggregate |
CN105219748A (en) * | 2015-10-10 | 2016-01-06 | 集美大学 | A kind of fermentation process of Escherichia coli fermentation Restruction arylsulfatase |
CN106399334A (en) * | 2016-08-05 | 2017-02-15 | 集美大学 | Thermally stable mutant aromatic sulfatase and its gene and use |
CN106399334B (en) * | 2016-08-05 | 2019-07-19 | 集美大学 | A kind of thermostable mutant aryl sulfatase, gene and application thereof |
CN110257439A (en) * | 2019-06-28 | 2019-09-20 | 集美大学 | A method of bio-ethanol is prepared using enzymatic treatment algal polysaccharides |
CN110257439B (en) * | 2019-06-28 | 2021-08-03 | 集美大学 | A kind of method that utilizes enzyme to process seaweed polysaccharide to prepare bio-ethanol |
CN110564791A (en) * | 2019-08-20 | 2019-12-13 | 集美大学 | Modified agar powder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104630248A (en) | Aryl sulfatase gene, protein encoded by aryl sulfatase gene as well as immobilization method and application of protein | |
CN106350531A (en) | Alginate lyase gene and application thereof | |
CN106191025B (en) | A kind of method that utilizes graphene oxide-metal ion coordination to immobilize enzyme | |
CN106119268B (en) | A method of improving alpha-L-Rhamnosidase r-Rha1 thermal stability | |
CN106148310B (en) | A kind of nitrilase mutant and its application in the preparation of nicotinic acid | |
CN114277004B (en) | High-temperature-resistant recombinant mutant SOD and encoding gene and application thereof | |
CN114410611B (en) | Laminarin degrading enzyme OUC-BsLam26 and its application | |
CN103602643A (en) | Recombinant Taq DNA polymerase and preparation method thereof | |
CN105062992B (en) | A kind of endolysin and the polynucleotides for encoding this endolysin | |
CN111500555B (en) | Chitosanase OUC-CsnCA and application thereof | |
CN112725319A (en) | Alginate lyase FaAly7 with polyG substrate specificity and application thereof | |
CN102994601A (en) | Method for preparing collagen small peptide by utilizing marine collagenase MCP-01 | |
CN102382790B (en) | A kind of recombined bacillus subtilis of high yield catalase and its construction method and application | |
CN107400666A (en) | A kind of aminopeptidase and its encoding gene and application | |
CN110643622A (en) | Alginate lyase gene and application thereof | |
CN104404026B (en) | A kind of polyethyleneimine titanium oxide for embedding amine dehydrogenase and preparation method thereof | |
CN111187764B (en) | Deep-sea-derived chitosanase CSN5, and coding gene and application thereof | |
TWI607087B (en) | Agarase, composition containing the same, and application thereof | |
CN106544336A (en) | A kind of nitrile hydratase improved by aliphatic dintrile regioselectivity | |
CN106544333A (en) | A kind of β agarases and its encoding gene and application | |
CN107446903B (en) | Salt-tolerant ethanol-tolerant pectinase with 3 optimal pH values and gene thereof | |
CN106085994B (en) | An Alkaline Pectinase Mutant with Increased Specific Enzyme Activity | |
CN113444721B (en) | A kind of artificially modified gene, SNA15 protein and its method for efficiently synthesizing nano silver | |
CN109652396A (en) | One Bacillus species chitinase and its preparation method and application | |
CN112725315B (en) | Application of chitosanase and mutant thereof in preparation of chitosan oligosaccharide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150520 |